DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Bangladesh
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
CENTRALPHL logo

Central Pharmaceuticals Ltd. Stock Price

DSE:CENTRALPHL Community·৳1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CENTRALPHL Share Price Performance

৳9.80
-0.40 (-3.92%)
​
৳9.80
-0.40 (-3.92%)
​
Price ৳9.80
Thu, 10 Sep 26
Share Pricen/a

CENTRALPHL Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
1 Reward
View Full Analysis

Central Pharmaceuticals Ltd. Key Details

৳36.1m

Revenue

৳47.5m

Cost of Revenue

-৳11.4m

Gross Profit

৳10.2m

Other Expenses

-৳21.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.18
-31.66%
-60.04%
32.9%
View Full Analysis

About CENTRALPHL

Founded
1980
Employees
75
CEO
Munsur Ahamed
WebsiteView website
www.centralpharmabd.com

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablets, capsules, liquids, and ointment. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective vitamins & minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, anti-diabetic oral rehydration salt, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAID; and skin diseases, such as fungal and bacterial infections, eczema, atopic dermatitis, other inflammatory skin diseases requiring corticosteroid therapy, and acne. Central Pharmaceuticals Ltd. was incorporated in 1980 and is headquartered in Dhaka, Bangladesh.

Recent CENTRALPHL News & Updates

Recent updates

No updates

Central Pharmaceuticals Ltd. Competitors

SQURPHARMA logo

Square Pharmaceuticals

Symbol: DSE:SQURPHARMA
Market cap: ৳191.1b
BXPHARMA logo

Beximco Pharmaceuticals

Symbol: DSE:BXPHARMA
Market cap: ৳67.2b
RENATA logo

Renata

Symbol: DSE:RENATA
Market cap: ৳52.9b
BEACONPHAR logo

Beacon Pharmaceuticals

Symbol: DSE:BEACONPHAR
Market cap: ৳24.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide